4
MARKET OVERVIEW
Outlines emerging trends, technology impact, and regulatory signals affecting growth trajectory and stakeholder decisions.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
This section summarizes market dynamics, key shifts, and high-impact trends shaping demand outlook.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMICS INDICATORS
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN CHINA & JAPAN HEALTHCARE INDUSTRY
5.2.4
TRENDS IN CHINA & JAPAN MEDICAL DEVICE INDUSTRY
5.3
SUPPLY CHAIN ANALYSIS
5.6.1
AVERAGE SELLING PRICE TREND, BY COUNTRY (2023-2025)
5.6.2
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE (2023-2025)
5.7.1
IMPORT SCENARIO (HS CODE 9018)
5.7.2
EXPORT SCENARIO (HS CODE 9018)
5.8
KEY CONFERENCES AND EVENTS, 2026–2027
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.10
INVESTMENT AND FUNDING SCENARIO
5.11
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
5.12
IMPACT OF 2025 US TARIFF – CHINA & JAPAN PERIPHERAL VASCULAR DEVICES MARKET
5.12.3
PRICE IMPACT ANALYSIS
5.12.4
IMPACT ON COUNTRIES
5.12.5
IMPACT ON HEALTHCARE PROVIDER SEGMENTS
5.12.5.2
AMBULATORY SURGICAL CENTERS
NOTE: OTHER END USERS INCLUDE SPECIALTY CLINICS, RESEARCH INSTITUTES & ACADEMIC MEDICAL CENTERS, GOVERNMENT & MILITARY HOSPITALS, AMONG OTHERS.
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.1.1
BIORESORBABLE PERIPHERAL SCAFFOLDS/STENTS
6.1.2
ROBOTIC ENDOVASCULAR INTERVENTION PLATFORMS
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
AI AND ADVANCED IMAGING IN PAD / VASCULAR INTERVENTION
6.2.2
INTRAVASCULAR LITHOTRIPSY
6.3
ADJACENT TECHNOLOGIES
6.3.1
IVUS-GUIDED PERIPHERAL & DEEP VENOUS INTERVENTIONS
6.3.2
PATIENT-SPECIFIC 3D PRINTING
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.7
IMPACT OF AI/GEN AI ON CHINA & JAPAN PERIPHERAL VASCULAR DEVICES MARKET
6.7.1
TOP USE CASES AND MARKET POTENTIAL
6.7.2
BEST PRACTICES IN CHINA & JAPAN PERIPHERAL VASCULAR DEVICES MARKET
6.7.3
CASE STUDIES OF AI IMPLEMENTATION IN THE CHINA & JAPAN PERIPHERAL VASCULAR DEVICES MARKET
6.7.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.7.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN CHINA & JAPAN PERIPHERAL VASCULAR DEVICES MARKET
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
SUSTAINABILITY INITIATIVES
7.2.1
ENERGY-EFFICIENT SYSTEM DESIGN AND USE OF RECYCLABLE MATERIALS IN PERIPHERAL VASCULAR DEVICES
7.3
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
7.4
CERTIFICATIONS, LABELING, ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
CHINA & JAPAN PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
COMPARATIVE ASSESSMENT OF KEY PERIPHERAL VASCULAR DEVICES, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS BY VARIOUS COMPANIES
Market Size, Volume & Forecast – USD Million
9.2
VOLUME ANALYSIS OF PERIPHERAL VASCULAR DEVICES, 2024 – 2031 (THOUSAND UNITS)
10
CHINA & JAPAN ANGIOPLASTY STENTS MARKET, BY TYPE (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
COMPARATIVE ASSESSMENT OF KEY ANGIOPLASTY STENTS, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS BY VARIOUS COMPANIES
Market Size, Volume & Forecast – USD Million
9.3.1
BARE-METAL STENTS, BY DELIVERY PLATFORM
9.3.1.1.1
BALLOON-EXPANDABLE STENTS.
9.3.1.1.2
SELF-EXPANDABLE STENTS
11
CHINA & JAPAN ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY TYPE (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
COMPARATIVE ASSESSMENT OF KEY ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS BY VARIOUS COMPANIES
Market Size, Volume & Forecast – USD Million
11.2
ABDOMINAL AORTIC ANEURYSM STENT GRAFTS
11.3
THORACIC AORTIC ANEURYSM STENT GRAFTS
12
CHINA & JAPAN CATHETERS MARKET, BY TYPE (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
COMPARATIVE ASSESSMENT OF KEY CATHETERS, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS BY VARIOUS COMPANIES
Market Size, Volume & Forecast – USD Million
12.2
ANGIOGRAPHY CATHETERS
13
CHINA & JAPAN INFERIOR VENA CAVA FILTERS MARKET, BY TYPE (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
COMPARATIVE ASSESSMENT OF KEY VENA CAVA FILTERS, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS BY VARIOUS COMPANIES
Market Size, Volume & Forecast – USD Million
14
CHINA & JAPAN ANGIOPLASTY BALLOONS MARKET, BY TYPE (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
COMPARATIVE ASSESSMENT OF KEY ANGIOPLASTY BALLOONS, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS BY VARIOUS COMPANIES
Market Size, Volume & Forecast – USD Million
14.3
DRUG-ELUTING BALLOONS
14.4
CUTTING & SCORING BALLOONS
14
CHINA & JAPAN PLAQUE MODIFICATION DEVICES MARKET, BY TYPE (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
COMPARATIVE ASSESSMENT OF KEY PLAQUE MODIFICATION DEVICES, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS BY VARIOUS COMPANIES
Market Size, Volume & Forecast – USD Million
14.3
THROMBECTOMY DEVICES
14
CHINA & JAPAN HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
COMPARATIVE ASSESSMENT OF KEY HEMODYNAMIC FLOW ALTERATION DEVICES, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS BY VARIOUS COMPANIES
Market Size, Volume & Forecast – USD Million
14.2
EMBOLIC PROTECTION DEVICES
14.3
CHRONIC TOTAL OCCLUSION DEVICES
14
CHINA & JAPAN OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
COMPARATIVE ASSESSMENT OF KEY OTHER PERIPHERAL VASCULAR DEVICES, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS BY VARIOUS COMPANIES
Market Size, Volume & Forecast – USD Million
14.3
VASCULAR CLOSURE DEVICES
14.3
BALLOON INFLATION DEVICES
15
CHINA & JAPAN PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
ASSESSING GROWTH PATTERNS, INDUSTRY FORCES, REGULATORY LANDSCAPE, AND MARKET POTENTIAL ACROSS KEY COUNTRIES
15.1
CHINA VOLUME ANALYSIS – 2024 – 2031 (THOUSAND UNITS)
15.2
MACROECONOMIC OUTLOOK FOR CHINA
15.1
JAPAN VOLUME ANALYSIS – 2024 – 2031 (THOUSAND UNITS)
15.2
MACROECONOMIC OUTLOOK FOR JAPAN
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
16.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
16.3
CHINA & JAPAN REVENUE SHARE ANALYSIS OF KEY PLAYERS (2021-2025)
16.4
MARKET SHARE ANALYSIS,
16.4.1
CHINA MARKET SHARE ANALYSIS,
16.4.2
JAPAN MARKET SHARE ANALYSIS,
16.5
PRODUCT COMPARATIVE ANALYSIS
16.5.1
TERUMO CORPORATION (MISAGO RX SELF-EXPANDING PERIPHERAL STENT)
16.5.2
MEDTRONIC (EVERFLEX SELF- EXPANDING PERIPHERAL STENT SYSTEM)
16.5.3
BOSTON SCIENTIFIC CORPORATION (ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM)
16.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
16.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
16.6.5.1
COMPANY FOOTPRINT
16.6.5.2
REGION FOOTPRINT
16.6.5.3
PERIPHERAL VASCULAR DEVICES FOOTPRINT
16.6.5.4
ANGIOPLASTY STENTS FOOTPRINT
16.6.5.5
CATHETERS FOOTPRINT
16.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
16.7.1
PROGRESSIVE COMPANIES
16.7.2
RESPONSIVE COMPANIES
16.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
16.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
16.7.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
16.8
COMPANY VALUATION AND FINANCIAL METRICS
16.9
COMPETITIVE SCENARIO
16.9.4
OTHER DEVELOPMENTS
IN-DEPTH REVIEW OF COMPANIES, PRODUCTS, RECENT INITIATIVES, AND POSITIONING STRATEGIES IN THE CHINA & JAPAN PERIPHERAL VASCULAR DEVICES MARKET LANDSCAPE
17.1.1
TERUMO CORPORATION
17.1.3
BOSTON SCIENTIFIC CORPORATION
17.1.5
MICROPORT SCIENTIFIC CORPORATION
17.1.6
W. L. GORE & ASSOCIATES, INC.
17.1.7
ASAHI INTECC CO., LTD.
17.2.1
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
17.2.2
ZHEJIANG BARTY MEDICAL TECHNOLOGY CO., LTD.
17.2.3
GLOBAL VASCULAR CO., LTD.
18.1.1.1
KEY DATA FROM SECONDARY SOURCES
18.1.2.1
KEY DATA FROM PRIMARY SOURCES
18.1.2.2
KEY PRIMARY PARTICIPANTS
18.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
18.1.2.4
KEY INDUSTRY INSIGHTS
18.2
MARKET SIZE ESTIMATION
18.2.1
BOTTOM-UP APPROACH
18.2.3
BASE NUMBER CALCULATION
18.3
MARKET FORECAST APPROACH
18.6
RESEARCH ASSUMPTIONS
18.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
19.2
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
19.3
CUSTOMIZATION OPTIONS
19.3.2
COMPANY INFORMATION
19.3.3
GEOGRAPHIC ANALYSIS
19.3.4
COUNTRY LEVEL MARKET SHARE ANALYSIS
19.3.5
COUNTRY LEVEL VOLUME ANALYSIS
19.3.6
BY TYPE MARKET SHARE ANALYSIS (TOP 5 PLAYERS)
19.3.7
ANY CONSULTS/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
*CONTENTS IN THE TOC/ MARKET SEGMENTS ARE TENTATIVE AND MIGHT CHANGE AS THE RESEARCH PROCEEDS.
*LIST OF COMPANIES IS NOT EXHAUSTIVE AND MIGHT CHANGE DURING COURSE OF STUDY
Growth opportunities and latent adjacency in China & Japan Peripheral Vascular Devices Market